✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Onesource Specialty Pharma Ltd.

ONESOURCE

Market Cap
₹18,003 Cr.
P/E
0.00

Onesource Specialty Pharma Ltd.

  • Onesource Specialty
  • Concord Biotech
  • Alembic Pharma
FAQs on Onesource Specialty Pharma Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Onesource Specialty is 0

View FAQ's On Business
Growth Table
  • Onesource Specialty Pharma Ltd.
  • Concord Biotech
  • Alembic Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Quarterly Results
  • Onesource Specialty Pharma Ltd.
  • Concord Biotech
  • Alembic Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Onesource Specialty Pharma Ltd. Financials

Onesource Specialty balance sheet is weak and might have solvency issues

Yes, The debt of Onesource Specialty is increasing.
Latest debt of Onesource Specialty is ₹0 Crs as of latest yr.
This is greater than previous yr when it was ₹0 Crs.

The profit is oscillating.
The profit of Onesource Specialty is ₹0 Crs for Mar 2025, ₹0 Crs for Mar 2024 and ₹0 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Onesource Specialty latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

NA

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech